5AM Ventures Passes Target on Fund Three
5AM Ventures, an early-stage venture capital firm focused on life sciences, has passed $150 million fundraising target on its third fund, according to a regulatory filing. It now has $159.2 million in capital commitments from 34 accredited investors, compared to $119.25 million disclosed in an April filing. The firm's second fund closed in 2006 with $150 million. Based in Waltham, Mass., and Menlo Park, Calif., 5AM was formed in 2004, raising a $65 million fund. It’s led by managing partners Andrew Schwab, Scott Rocklage and John Diekman.
6 July 2009•1 min read
